MX9604109A - Agente para disminuir la tension ocular. - Google Patents

Agente para disminuir la tension ocular.

Info

Publication number
MX9604109A
MX9604109A MX9604109A MX9604109A MX9604109A MX 9604109 A MX9604109 A MX 9604109A MX 9604109 A MX9604109 A MX 9604109A MX 9604109 A MX9604109 A MX 9604109A MX 9604109 A MX9604109 A MX 9604109A
Authority
MX
Mexico
Prior art keywords
alkyl
formula
alkenyl
agent
group
Prior art date
Application number
MX9604109A
Other languages
English (en)
Spanish (es)
Inventor
Tomihisa Yokoyama
Tsunemichi Hosokawa
Hiroaki Yanagisawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of MX9604109A publication Critical patent/MX9604109A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX9604109A 1994-03-16 1995-03-16 Agente para disminuir la tension ocular. MX9604109A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4540494 1994-03-16
PCT/JP1995/000444 WO1995024902A1 (en) 1994-03-16 1995-03-16 Ocular tension depressant

Publications (1)

Publication Number Publication Date
MX9604109A true MX9604109A (es) 1997-09-30

Family

ID=12718322

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9604109A MX9604109A (es) 1994-03-16 1995-03-16 Agente para disminuir la tension ocular.

Country Status (20)

Country Link
US (1) US5925664A (enExample)
EP (2) EP1110551B1 (enExample)
KR (1) KR100211446B1 (enExample)
CN (2) CN1104898C (enExample)
AT (2) ATE206050T1 (enExample)
AU (1) AU684916B2 (enExample)
CZ (1) CZ284395B6 (enExample)
DE (2) DE69533045T2 (enExample)
DK (2) DK1110551T3 (enExample)
ES (2) ES2163501T3 (enExample)
FI (2) FI114897B (enExample)
GR (1) GR3036989T3 (enExample)
HK (1) HK1000551A1 (enExample)
HU (1) HUT74734A (enExample)
MX (1) MX9604109A (enExample)
NO (1) NO311068B1 (enExample)
NZ (1) NZ282485A (enExample)
PT (2) PT1110551E (enExample)
RU (1) RU2123847C1 (enExample)
WO (1) WO1995024902A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300553B6 (cs) * 1999-06-11 2009-06-17 Sankyo Company Limited Místne podávané prostredky ke snížení nitroocního tlaku
TWI290470B (en) * 1999-12-01 2007-12-01 Sankyo Co The composition for treating glaucoma
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
WO2002045748A1 (en) * 2000-12-05 2002-06-13 Sankyo Company, Limited Ocular tension-lowering compositions for topical administration
ES2535291T3 (es) * 2003-04-15 2015-05-08 Daiichi Sankyo Company, Limited Medoxomilo de olmesartán para prevención o tratamiento de enfermedades oculares angiogénicas

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549049B1 (fr) * 1983-07-13 1986-06-20 Chauvin Blache Lab Nouvelles amidines, leur procede de preparation et leur application therapeutique
ZA875052B (en) * 1986-07-11 1989-03-29 Du Pont Angiotensin ii receptor blocking imidazoles
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
DK0479903T3 (da) * 1989-06-30 1996-03-18 Du Pont Substituerede imidazoler og deres anvendelse som angiotensin II hæmmere
WO1991015206A1 (en) * 1990-04-05 1991-10-17 E.I. Du Pont De Nemours And Company Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5126342A (en) * 1990-10-01 1992-06-30 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating acidic functional groups
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
CA2061607C (en) * 1991-02-21 1999-01-19 Hiroaki Yanagisawa 1-biphenylimidazole derivatives, their preparation and their therapeutic use
DE4132631A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Imidazolyl-propensaeurederivate
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
DK0573218T3 (da) * 1992-06-02 2001-06-18 Sankyo Co 4-carboxyimidazolderivater som angiotensin-II antagonister og deres terapeutiske anvendelse
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
CZ283315B6 (cs) * 1992-12-17 1998-02-18 Sankyo Company Limited Bifenylové deriváty, způsob výroby a farmaceutické prostředky k léčení hypertense a srdečních onemocnění, které tyto deriváty obsahují
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
DK0743852T3 (da) * 1994-02-08 2005-10-17 Novartis Ag Behandling af glaukom med normalt tryk med valsartan

Also Published As

Publication number Publication date
KR100211446B1 (ko) 1999-08-02
FI20041236L (fi) 2004-09-24
WO1995024902A1 (en) 1995-09-21
DE69533045D1 (de) 2004-06-17
NO963854L (no) 1996-11-14
EP1110551A2 (en) 2001-06-27
EP0795326B1 (en) 2001-09-26
HU9602534D0 (en) 1996-11-28
CN1387846A (zh) 2003-01-01
PT1110551E (pt) 2004-07-30
RU2123847C1 (ru) 1998-12-27
NO963854D0 (no) 1996-09-13
ES2163501T3 (es) 2002-02-01
DE69533045T2 (de) 2005-01-27
FI115197B (fi) 2005-03-31
NO311068B1 (no) 2001-10-08
AU684916B2 (en) 1998-01-08
AU1960295A (en) 1995-10-03
DE69522955T2 (de) 2002-05-29
DK1110551T3 (da) 2004-06-07
EP0795326A1 (en) 1997-09-17
FI114897B (fi) 2005-01-31
CN1104898C (zh) 2003-04-09
KR970701542A (ko) 1997-04-12
DE69522955D1 (de) 2001-10-31
CN1202819C (zh) 2005-05-25
ES2221872T3 (es) 2005-01-16
CN1148809A (zh) 1997-04-30
EP1110551A3 (en) 2001-08-16
PT795326E (pt) 2002-01-30
CZ284395B6 (cs) 1998-11-11
CZ269496A3 (en) 1996-12-11
ATE266402T1 (de) 2004-05-15
NZ282485A (en) 1997-06-24
EP0795326A4 (enExample) 1997-09-17
HUT74734A (en) 1997-02-28
HK1000551A1 (en) 2002-04-12
FI963645A0 (fi) 1996-09-16
ATE206050T1 (de) 2001-10-15
EP1110551B1 (en) 2004-05-12
DK0795326T3 (da) 2001-11-26
FI963645A7 (fi) 1996-11-14
GR3036989T3 (en) 2002-01-31
US5925664A (en) 1999-07-20

Similar Documents

Publication Publication Date Title
NO304111B1 (no) Heteroeddiksyrederivater, farmas°ytiske midler inneholdende dem samt deres anvendelse for fremstilling av farmas°ytiske preparater
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
DE69310501D1 (de) Chinolylbenzofuran derivate als leukotrien-antagonisten
ATE223716T1 (de) Verwendung einer amphipatischen, kationischen verbindung als transfektionmittel,als impfstoffadjuvans oder als medikament
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
BG101402A (en) Apoliprotein-b synthesis inhibitors
MX9604109A (es) Agente para disminuir la tension ocular.
MY106314A (en) New tetrazole derivatives, process for their preparation and their use
CO4750814A1 (es) Nuevos derivados de fenilamidina, su procedimiento para su preparacion y su utilizacion como medicamentos
CO4130335A1 (es) Nuevos productos farmaceuticos que son piranoquinolinas sus- tituidas con fenilos o heteroarilos
GB1531946A (en) Cyclopentane derivatives useful as perfuming agents
ATE228520T1 (de) Lactamverbindungen als inhibitoren der cholesterin-esterase
ES8401928A1 (es) Procedimiento de obtencion de composiciones oftalmologicas.
PE59299A1 (es) Procedimiento para la preparacion de eprosartano
AR001150A1 (es) Nuevo procedimiento para preparar derivados 2,3-dihidrobenzofuranol
DE59808546D1 (de) Verwendung von fettsäureniedrigalkylestern in abbeizmitteln
NO842534L (no) Fremgangsmaate ved fremstilling av nye prostacyclinderivater
KR950032158A (ko) 신규의 티아진 또는 티오모폴린 유도체
CA2185524A1 (en) Ocular tension depressant
EP0627425A4 (enExample)
DE69303917D1 (de) Färbemittel für keratinische Fasern, die 4-Monoindolyl 1,2-naphthochinone enthalten, 4-Monoindolyl 1,2-naphthochinone
ES8404338A1 (es) Procedimiento para la obtencion de oxazolidin-2-onas.
ES2071713T3 (es) N-heterociclometil-spiroheterociclos y los fungicidas que les contienen.
CO4940508A1 (es) 2,4-diaminopirimidina substituida

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees